Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Brain, Behavior, & Immunity - Health
|
January 21, 2025
The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
Rojin Sarallah, Shima Jahani, Alireza Soltani Khaboushan, et al.
Health Science Reports
|
April 20, 2026
Global Prevalence and Risk Factors of Suicidal Ideation in Multiple Sclerosis: A Systematic Review and Meta-Analysis
Elham Bazmi, Amir Hossein Behnoush, Mahsa Mohammadi Lapevandani, et al.
Acta Neurologica Belgica
|
January 30, 2026
Exit strategy patterns in second-line therapies for relapsing forms of multiple sclerosis
Ali Rezaei, Nasim Rezaeimanesh, Kosar Kohandel, et al.
Acta Neurologica Belgica
|
April 5, 2025
Parental smoking before childbirth and multiple sclerosis onset in their child: a case-control study
Sanaz Khodadadi, Sahar Nikkhah Bahrami, Shima Jahani, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 27, 2025
Environmental risk factors of late-onset multiple sclerosis: A population-based case-control study
Naghmeh Abbasi Kasbi, Shima Jahani, Sajjad Ghane Ezabadi, et al.
Stem Cell Research & Therapy
|
November 20, 2024
Human studies of the efficacy and safety of stem cells in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis
Seyed Danial Alizadeh, Shima Jahani, Mohammad Rezaei Zadeh Rukerd, et al.
Multiple Sclerosis and Related Disorders
|
January 26, 2026
Post-infusion observation of patients with multiple sclerosis receiving natalizumab: Is it necessary?
Melika Arab Bafrani, Negar Sadat Ahmadi, Fateme Zahra Idjadi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
August 13, 2025
Optimizing premedications for multiple sclerosis patients treated with ocrelizumab: A randomized controlled trial
Naghmeh Abbasi Kasbi, Ali Rezaei, Reyhaneh Montazeri, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
|
September 1, 2019
Trends in the drowning mortality rate in Iran
Pegah Derakhshan, Sahar Saeedi Moghaddam, Soheil Saadat, et al.
Neurology and Therapy
|
July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis
Mahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Brain, Behavior, & Immunity - Health
|
January 21, 2025
The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
Rojin Sarallah, Shima Jahani, Alireza Soltani Khaboushan, et al.
Health Science Reports
|
April 20, 2026
Global Prevalence and Risk Factors of Suicidal Ideation in Multiple Sclerosis: A Systematic Review and Meta-Analysis
Elham Bazmi, Amir Hossein Behnoush, Mahsa Mohammadi Lapevandani, et al.
Acta Neurologica Belgica
|
January 30, 2026
Exit strategy patterns in second-line therapies for relapsing forms of multiple sclerosis
Ali Rezaei, Nasim Rezaeimanesh, Kosar Kohandel, et al.
Acta Neurologica Belgica
|
April 5, 2025
Parental smoking before childbirth and multiple sclerosis onset in their child: a case-control study
Sanaz Khodadadi, Sahar Nikkhah Bahrami, Shima Jahani, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 27, 2025
Environmental risk factors of late-onset multiple sclerosis: A population-based case-control study
Naghmeh Abbasi Kasbi, Shima Jahani, Sajjad Ghane Ezabadi, et al.
Stem Cell Research & Therapy
|
November 20, 2024
Human studies of the efficacy and safety of stem cells in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis
Seyed Danial Alizadeh, Shima Jahani, Mohammad Rezaei Zadeh Rukerd, et al.
Multiple Sclerosis and Related Disorders
|
January 26, 2026
Post-infusion observation of patients with multiple sclerosis receiving natalizumab: Is it necessary?
Melika Arab Bafrani, Negar Sadat Ahmadi, Fateme Zahra Idjadi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
August 13, 2025
Optimizing premedications for multiple sclerosis patients treated with ocrelizumab: A randomized controlled trial
Naghmeh Abbasi Kasbi, Ali Rezaei, Reyhaneh Montazeri, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
|
September 1, 2019
Trends in the drowning mortality rate in Iran
Pegah Derakhshan, Sahar Saeedi Moghaddam, Soheil Saadat, et al.
Neurology and Therapy
|
July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis
Mahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Page
of 2